Detalles de la búsqueda
1.
Vascular Risk Predicts Plasma Amyloid ß 42/40 Through Cerebral Amyloid Burden in Apolipoprotein E ε4 Carriers.
Stroke
; 54(5): 1227-1235, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021572
2.
A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
Brain
; 143(5): 1315-1331, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31891371
3.
Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
Mov Disord
; 32(12): 1720-1728, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28880465
4.
Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults.
Int J Geriatr Psychiatry
; 31(5): 502-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26343804
5.
Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
Mov Disord
; 29(3): 368-74, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24395213
6.
Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
J Alzheimers Dis
; 85(2): 545-560, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864669
7.
Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume.
Alzheimers Dement (Amst)
; 14(1): e12349, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36092690
8.
Brain atrophy trajectories predict differential functional performance in Alzheimer's disease: Moderations with apolipoprotein E and sex.
Alzheimers Dement (Amst)
; 13(1): e12244, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34692981
9.
A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented Aging.
Front Aging Neurosci
; 13: 621023, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34603005
10.
A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1â+âPICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEÉ4 Carriers.
J Alzheimers Dis
; 62(2): 887-900, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29480189
11.
Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women.
Alzheimers Res Ther
; 10(1): 89, 2018 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30185213
12.
Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
J Alzheimers Dis
; 65(4): 1401-1416, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30175979
13.
Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers.
Front Aging Neurosci
; 10: 296, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30333744
14.
Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.
Neurobiol Aging
; 52: 81-89, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28131014
15.
Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.
Neurobiol Aging
; 42: 91-100, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27143425
16.
Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.
Neurobiol Aging
; 36(1): 249-56, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25107496
Resultados
1 -
16
de 16
1
Próxima >
>>